Medicine composition used for treating lung and kidney qi deficiency type chronic obstructive emphysema and preparation method thereof

Abstract

The invention discloses a medicine composition used for treating lung and kidney qi deficiency type chronic obstructive emphysema and a preparation method thereof. Raw medicine materials of the medicine composition comprise, astragalus, convolvulate asiabell roots, amomum, Chinese yam, mica, cordyceps liangshanensis, walnut kernels, agilawood, fructus psoraleae, fructus schizandrae, ginkgo, semen ziziphi spinosae, nutgall, polygonum cynanchoides hemsl, caulis bambusae in taeniis, caudate sweetleaf flowers, artemisia vestita, herbs of little platanthera, cerealose, white fungi and jujubes. The medicine composition has the advantages that the medicine composition is mainly used for nourishing the kidney and lung and preventing asthma and assists in astringing the lung to stop cough and regulating qi-flowing for eliminating phlegm, treats the lung and kidney qi deficiency type chronic obstructive emphysema, and has the advantages of being quick in working, accurate in treatment effect, high in safety, free of toxic function and not prone to reappearing.

Description

[0001] technical field [0002] The invention relates to the technical field of pharmacy, in particular to a pharmaceutical composition for treating chronic obstructive emphysema of lung and kidney qi deficiency and a preparation method thereof. [0003] Background technique [0004] Obstructive emphysema is chronic obstructive pulmonary emphysema, strictly speaking emphysema is not a disease in its own right but an anatomical / structural term that results from the development of chronic bronchitis or other chronic lung disease. Mainly the expansion and hyperinflation of the distal part of the terminal bronchi of lung tissue, including respiratory bronchioles, alveolar ducts, alveolar sacs, and alveoli, resulting in decreased elasticity and increased volume of lung tissue. Because of its slow onset and long course, it is called chronic obstructive emphysema. In my country, the incidence rate is about 0.6% to 4.3%. [0005] The etiology of chronic obstructive emphysema has ...

AI Technical Summary

Problems solved by technology

[0007] At present, domestic treatment methods for chronic obstructive emphysema mainly include surgery, positive pressure ventilation, drug therapy, traditional Chinese medicine therapy, integrated traditional Chinese and Western medicine therapy, acupuncture and moxibustion therapy, and rehabilitation training. Treatment and other main means, surgery is relatively harmful to the human body, drug treatment is mainly based on glucocorticoids, glucocorticoids can suppress the immune function of the body, and have no antibacterial effect, long-term use can often induce infection or aggravate infection, It can spread latent infection foci in the body or reactivate dormant infection foci, and can also cause other complications, because the side effects on the human body are relatively large